Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 2Recruiting 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 9Breast 7Gynecologic 3Tumor-Agnostic 2Thoracic 2Other hematologic neoplasm 2Head & Neck 2NET 1Lymphoid 1Endocrine 1Dermatologic 1Classical hematology 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Leukemia, Myeloid, Acute 1

Interventions

Cyclophosphamide 174Rituximab 146venetoclax 82Specimen Handling 81fludarabine 80Vincristine 69obinutuzumab 68Prednisone 66Doxorubicin 66Biopsy 63Magnetic Resonance Spectroscopy 62Lenalidomide 54zanubrutinib 52Dexamethasone 48Cytarabine 44Methotrexate 43blinatumomab 41Immunotherapy, Adoptive 40acalabrutinib 37Bendamustine Hydrochloride 37fludarabine phosphate 32Etoposide 32ibrutinib 30polatuzumab vedotin 27glofitamab 27pirtobrutinib 25orelabrutinib 25Gemcitabine 24Injections 21Mercaptopurine 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Control Groups × Lymphoid × Clear all
NCT06816134 2026-04-23

Study on the Efficacy and Safety of the TmBU Conditioning Regimen in High-risk or Relapsed/Refractory Acute Leukemia

The First Affiliated Hospital of Soochow University

Phase 2 Recruiting
48 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡